Literature DB >> 9659579

Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.

L Lin1, M F Festing, T R Devereux, K A Crist, S C Christiansen, Y Wang, A Yang, K Svenson, B Paigen, A M Malkinson, M You.   

Abstract

A locus for mouse pulmonary adenoma susceptibility, Pas-1, has been mapped on distal chromosome 6, where the K-ras gene is located. Allele-specific activation and expression of the K-ras allele from the susceptible parent has been observed in lung tumors from F1 hybrid mice. We report here genetic mapping of lung tumor susceptibility genes in urethane-treated A x B and B x A recombinant inbred (RI) mice using microsatellite markers to seek further evidence for the K-ras gene as candidate for Pas-1. The K-ras genotype differs between the A/J and C57BL/6J progenitors of the RI strains, and distal chromosome 6 contained a major lung tumor susceptibility determinant in the RI mice. Additional evidence that Pas-1 is K-ras involved linkage analysis of (A/JOLaHsd x BALB/ cOLaHsd) F2 intercross mice whose parents shared the same K-ras genotype. In contrast to the results with the A x B and B x A RI strains, no distal chromosome 6 site was significantly associated with tumor development in these F2 mice. In addition to this major locus, linkage analysis of the RI mice revealed additional quantitative trait loci for susceptibility on chromosomes 10, 17, and 19. These loci may serve as modifiers of Pas-1. The relationship between the K-ras genotype and the frequency of K-ras mutations in urethane-induced lung tumors from the RI mice was also explored. All 18 tumor DNAs from RI mice with high susceptibility contained an AT-->TA transversion at the second base of K-ras codon 61. This was also true for DNAs from 27 of 27 (100%) tumors in mice with high intermediate susceptibility. In RI strains with a low intermediate susceptibility, the DNA from 39 of 47 (83%) tumors contained an AT-->TA transversion at codon 61, and only 13 of 21 (62%) tumors had this mutation in the most resistant group. This reflects a positive correlation between the frequency of K-ras mutations in lung tumors of A x B or B x A RI strains and their susceptibility to lung carcinogenesis. Since K-ras appears to be Pas-1, these results suggest that some RI mice that have the resistant K-ras or Pas-1 allele undergo tumor development by a K-ras-independent route.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659579     DOI: 10.3109/01902149809087382

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  15 in total

1.  Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility.

Authors:  Seddigheh Razani-Boroujerdi; Mohan L Sopori
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-27       Impact factor: 6.914

2.  Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.

Authors:  M Christine Hollander; Robyn T Philburn; Andrew D Patterson; Susana Velasco-Miguel; Errol C Friedberg; R Ilona Linnoila; Albert J Fornace
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

3.  Bronchioloalveolar neoplasia.

Authors:  Hitoshi Kitamura; Koji Okudela
Journal:  Int J Clin Exp Pathol       Date:  2010-11-12

4.  A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice.

Authors:  M Christine Hollander; Xin Zhou; Colleen R Maier; Andrew D Patterson; Xinxin Ding; Phillip A Dennis
Journal:  Carcinogenesis       Date:  2011-05-30       Impact factor: 4.944

5.  Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells.

Authors:  A Ehrhardt; T Bartels; R Klocke; D Paul; R Halter
Journal:  J Cancer Res Clin Oncol       Date:  2003-02-19       Impact factor: 4.553

6.  Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.

Authors:  Melody L Stallings-Mann; Jens Waldmann; Ying Zhang; Erin Miller; Mona L Gauthier; Daniel W Visscher; Gregory P Downey; Evette S Radisky; Alan P Fields; Derek C Radisky
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

7.  Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains.

Authors:  Lori D Dwyer-Nield; Jay McQuillan; Annie Hill-Baskin; Richard A Radcliffe; Ming You; Joseph H Nadeau; Alvin M Malkinson
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

8.  Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays.

Authors:  W J Lemon; H Bernert; H Sun; Y Wang; M You
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

9.  Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice.

Authors:  Mary Christine Hollander; Andria R Balogh; Jaminelli Liwanag; Wei Han; Ritva Ilona Linnoila; Miriam R Anver; Phillip A Dennis
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

10.  Requirement for MUC5AC in KRAS-dependent lung carcinogenesis.

Authors:  Alison K Bauer; Misha Umer; Vanessa L Richardson; Amber M Cumpian; Anna Q Harder; Nasim Khosravi; Zoulikha Azzegagh; Naoko M Hara; Camille Ehre; Maedeh Mohebnasab; Mauricio S Caetano; Daniel T Merrick; Adrie van Bokhoven; Ignacio I Wistuba; Humam Kadara; Burton F Dickey; Kalpana Velmurugan; Patrick R Mann; Xian Lu; Anna E Barón; Christopher M Evans; Seyed Javad Moghaddam
Journal:  JCI Insight       Date:  2018-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.